Accès libre

Severe haemophilia A with haemarthrosis improved on emicizumab: A case report

Mustafa Wasifuddin

Mustafa Wasifuddin

Department of Medicine, Brookdale University Hospital and Medical CenterBrooklyn, USA
Profil Orcid
Recherchez cet auteur sur
Sciendo|Google Scholar
Wasifuddin, Mustafa
 et 
Ibrahim Al-Gaithi

Ibrahim Al-Gaithi

Department of Pediatric Hematology/Oncology, Royal Hospital, Ministry of HealthMuscat, Oman
Profil Orcid
Recherchez cet auteur sur
Sciendo|Google Scholar
Al-Gaithi, Ibrahim
  
19 mars 2025
Severe haemophilia A with haemarthrosis improved on emicizumab: A case report's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Télécharger la couverture
Catégorie d'article: Case Study
Publié en ligne: 19 mars 2025
Pages: 29 - 33
DOI: https://doi.org/10.2478/jhp-2025-0004
Mots clés
© 2025 Mustafa Wasifuddin et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1.

Timeline showing key events in the case reported, from haemophilia diagnosis to treatment with emicizumab.ABR: Annualised Bleed Rate; MRI: Magnetic Resonance Imaging
Timeline showing key events in the case reported, from haemophilia diagnosis to treatment with emicizumab.ABR: Annualised Bleed Rate; MRI: Magnetic Resonance Imaging
Langue:
Anglais
Périodicité:
1 fois par an
Sujets de la revue:
Médecine, Sciences médicales de base, Sciences médicales de base, autres, Médecine clinique, Médecine clinique, autres, Pharmacie, Pharmacologie
RSS Feed de la revue